Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors-Reference-Cited by-同舟云学术

Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors

Published:2012-01 Issue:1-2 Volume:205 Page:42-54
ISSN:2210-7762
Container-title:Cancer Genetics
language:en
Short-container-title:Cancer Genetics

Author:

Dougherty Margaret J.,Tooke Laura S.,Sullivan Lisa M.,Hakonarson Hakon,Wainwright Luanne M.,Biegel Jaclyn A.

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference19 articles.

1. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital abnormalities;Miller;Am J Hum Genet,2010

2. Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies;Dougherty;Cancer Genet,2011

3. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays;Lindblad-Toh;Nat Biotechnol,2000

4. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays;Mei;Genome Res,2000

5. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays;Zhao;Cancer Res,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor‐forming potential in an early‐stage prostate cancer epithelial subline (M2205);Molecular Genetics & Genomic Medicine;2023-10-30

2. Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG);Genetics in Medicine;2021-10

3. Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib;Cancer Biology & Therapy;2021-03-04

4. Clinical Validation of Somatic Mutation Detection by the OncoScan CNV Plus Assay;The Journal of Molecular Diagnostics;2021-01

5. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC);Genetics in Medicine;2019-09